# Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain

> **NCT01207596** · PHASE4 · COMPLETED · sponsor: **International Clinical Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT01207596
- **Lead sponsor:** International Clinical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207596, "Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01207596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*